1. Research Collaborations

    International Collaborations

    • Prof. Shiv Pillai, Medicine and Health Sciences & Technology (HST), Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA – Development of Antiviral Coatings to Prevent the Transmission of SARS-CoV-2.
    • Prof. L. W. Hamoen, University of Amsterdam, Netherlands - Cell division protein inhibition.
    • Prof. Cristiano Marcelo Espinola Carvalho, Dom Bosco Catholic University, Brazil - Development of semisynthetic glycopeptide and betalactam derivatives.
    • Prof. Tatiana V. Ovchinnikova, Institute of Bioorganic Chemistry Russian Academy Sciences (RAS), Russia - Development of semisynthetic glycopeptide and betalactam derivatives.
    • Prof. Hixen Xie, East University Science Technology, China - Development of semisynthetic glycopeptide and betalactam derivatives.
    • Prof. Julia Bandow, Rhur-Univ. of Bochum, Germany - Development of semisynthetic glycopeptide and betalactam derivatives.
    • Prof. Octa´vio L. Franco, Universidade Catolica Dom Bosco, Campo Grande, Brazil - In vivo infection study.
    • Prof. Lorenzo Stella, University of Rome, Italy – Investigation of antibacterial mechanism of actions.
    • Prof. Peter Monk, Department of Infection, University of Sheffield, UK - Ex-vivo infection study.
    • Prof. M. N. Seleem, Department of Comparative Pathobiology, Purdue University, USA - Antifungal studies.
    • Prof. Bechinger Burkhard, Chemistry Institute, University of Strasbourg, France - Biophysical investigations of small antimicrobial peptide mimetics.
    • Dr. Mark Sutton, Public Health of England (PHE), UK - Anti-Ebola activity.
    • Dr. Nandyala Sooraj Hussain, University of Porto - Antimicrobial composites for bone infections.
    • Dr. Jean-Pierre Gorvel, Centre d’Immunologie de Marseille-Luminy, Aix-Marseille University, France - Development of prophylactic particulate vaccines for infectious diseases.
    • Prof. Padmini Salgame from Rutgers-New Jersey Medical School - Anti-tuberculosis study with Membrane active molecules.
    • Dr Carmen Domene from, King's College London - Theoretical study to understand the aggregation properties of cleavable amphiphiles.
    • Dr. Rafal Slusarz, University of Gdańsk, Poland - Theoretical study to understand high antibacterial activity of sugar conjugated Vancomycin analogues.
    • Prof. Themis Lazaridis, City College of New York - Theoretical study to understand the selective antibacterial activity of Small molecular peptoid mimics.
    • Dr. Leendert Hamoen, University of Amsterdam, Netherlands - Mechanism of action of membrane active molecules.
    • Dr. S. Vasan, Public Health of England (PHE) on anti-Ebola activity.

    National Collaborations

    • Prof. B. R. Shome & Dr. P. Krishanmoorthy, ICAR-NIVEDI, Bengaluru, India - In vivo infection study.
    • Dr. Prashant Garg, LV Prasad Eye Institute, Hyderabad, India - Ex-vivo eye infection study.
    • Dr. V. K. Aswal, BARC, Mumbai, India - SANS studies for aggregation behavior of gemini surfactants.
    • Dr. Utpal Tatu, Biochemistry, Indian Institute of Science, Bangalore, India - Antimalarial study.
    • Dr. Shridhar Narayanan, FNDR, Bangalore, India - Activity against Mycobacterium tuberculosis.
    • Dr. Suresh Kumar Jewrajka, CSIR-CSMCRI, India - Development of antibacterial filtration membrane.
    • Dr. Colin Jamora, In-Stem Joint Laboratory, NCBS, India - In vivo study on wound healing by hydrogel.
    • Prof. Satyavani Vemparala, Institute of Mathematical Sciences, Chennai, India - Theoretical study (MD Simulation) for Membrane
    • Dr. Chandra, Vipragen Biosciences, India – Outlicenced our inventions
    • Prof. Siddharth Chopra, CSIR-CDRI, Lucknow, India - Antibacterial studies.
    • Prof. Nisanth N Nair, IIT-Kanpur, India - Theoretical study (MD Simulation) for betalactamase.
    • Dr. R Ravikumar, NIMHANS, Bangalore, India - Development of novel antimicrobial agents to overcome microbial resistance against clinical isolates.
    • Prof. Somenath Roy, Vidyasagar University, Midnapore - Studies against clinical isolates of Vancomycin resistant bacteria.
    • Dr. Ganesh, Anthem biosciences, Bangalore, India - Antibacterial activity against vancomycin resistant bacteria.
    • Prof. C. Narayana, JNCASR, Bangalore, India - Mechanism of action through Raman spectroscopic studies.
    • Dr. Meher K Prakash, JNCASR, Bangalore, India - Theoretical study (MD Simulation)- for Membrane
    • Dr. Ravi Manjithaya, MBGU, JNCASR, Bangalore, India – Autophagy studies.
    • Prof. Kaustav Sanyal, MBGU, JNCASR, Bangalore, India - Antifungal studies.